Ignite Creation Date:
2024-05-06 @ 7:22 AM
Last Modification Date:
2024-10-26 @ 11:47 AM
Study NCT ID:
NCT02520050
Status:
COMPLETED
Last Update Posted:
2019-03-04
First Post:
2015-08-04
Brief Title:
The Effect of 3 Different Models of MNT on DM Control in Overweight Patients With T2DM
Sponsor:
Joslin Diabetes Center
Organization:
Joslin Diabetes Center
Study Overview
Official Title:
The Effect of Three Different Models of Medical Nutrition Therapy MNT on Diabetes Control in Overweight and Obese Patients With Type 2 Diabetes A Randomized Comparative Study Nutrition Path Study
Status:
COMPLETED
Status Verified Date:
2019-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The American Diabetes Association ADA among other medical societies is strongly recommending medical nutrition therapy MNT for prevention and management of type 2 diabetes However the ADA recognized that there is no one size fits all diet and thus recommends that MNT should be conducted through a consultation with registered dietitians RD Previous studies have shown that using diabetes-specific nutritional formulas as an integral part of the MNT lowers postprandial blood glucose levels Through our experience from the Joslins Weight Achievement and Intensive Treatment Why WAIT program applying MNT within a structured dietary intervention protocol has the best impact on blood glucose values and body weight Meanwhile the frequent use of health coaching during dietary intervention proved to be effective in managing diabetes and inducing weight loss However no study compared those three intervention methods in a randomized clinical study
The aim of this study is to evaluate the effect of different models of conducting medical nutrition therapy on the glycemic control in patients with type 2 diabetes
The aim of this study is to evaluate the effect of different models of conducting medical nutrition therapy on the glycemic control in patients with type 2 diabetes
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None